{"created":"2023-05-15T16:44:15.583137+00:00","id":19894,"links":{},"metadata":{"_buckets":{"deposit":"72d52646-45f3-4e79-8610-32f6d5ed88aa"},"_deposit":{"created_by":2,"id":"19894","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"19894"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00019894","sets":["29:30:1713167819629:1380"]},"author_link":["83348","83346","83342","83343","83344","83341","83345","83347"],"item_3_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1992-12-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1/4","bibliographicPageEnd":"113","bibliographicPageStart":"110","bibliographicVolumeNumber":"37","bibliographic_titles":[{"bibliographic_title":"Acta Medica Nagasakiensia"}]}]},"item_3_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"This study was performed for the evaluation of combined effects of OK-432 and anticancer agents on K562 cells in vitro. On the growth curve, an increase of cytocidl effects was not observed by co-operative action of OK-432 and Cisplatin, but such increase was found with OK-432 and VP-16. It was evident than there are the difference depending on the type of anticancer agent combined with OK-432. When this difference was investigated on the cell cycle, G2M phase accumulation was delayed with OK-432 and Cisplatin. On the other hand, this delay was not observed with OK-432 and VP-16. It was suggested that the degree of this G2M phase accumulation might affect the cytocidal effects on cancer cells.","subitem_description_type":"Abstract"}]},"item_3_description_64":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"Acta Medica Nagasakiensia. 1992, 37(1-4), p.110-113","subitem_description_type":"Other"}]},"item_3_source_id_10":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA00508430","subitem_source_identifier_type":"NCID"}]},"item_3_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00016055","subitem_source_identifier_type":"ISSN"}]},"item_3_text_62":{"attribute_name":"sortkey","attribute_value_mlt":[{"subitem_text_value":"P00110-P00113"}]},"item_3_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Tagawa, Yutaka"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakazaki, Takayuki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sawai, Terumitsu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Akama, Fumitaka"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Jibiki, Masaaki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Yamaguchi, Shinya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Matsuo, Toshikazu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Tomita, Masao"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-23"}],"displaytype":"detail","filename":"acta37_01-04_24_t.pdf","filesize":[{"value":"479.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"acta37_01-04_24_t.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/19894/files/acta37_01-04_24_t.pdf"},"version_id":"6e85f126-0f89-4d58-a08f-c0eb10f31865"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"OK-432, Cisplatin, VP-16, Cell cycle","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"A Study of Cytocidal Effects According to the Type of Anticancer Agent Combined with OK-432","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"A Study of Cytocidal Effects According to the Type of Anticancer Agent Combined with OK-432"}]},"item_type_id":"3","owner":"2","path":["1380"],"pubdate":{"attribute_name":"公開日","attribute_value":"2008-06-20"},"publish_date":"2008-06-20","publish_status":"0","recid":"19894","relation_version_is_last":true,"title":["A Study of Cytocidal Effects According to the Type of Anticancer Agent Combined with OK-432"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2024-04-17T04:09:13.343688+00:00"}